Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, External Quality Operations

Employer
Homology Medicines
Location
Bedford, MA
Start date
Jan 3, 2019

View more

Discipline
Quality, Quality Assurance, Quality Control
Required Education
Masters Degree/MBA
Position Type
Full time

Job Details

Associate Director, External Quality Operations

Location: Bedford, MA

Job Code:ADG0033-18

 

The Senior Manager , External Quality Operations  will be responsible for managing external quality operations of gene therapy products.. This role includes ownership of the external disposition process, QA liaison to contract manufacturing organizations (CMO),  contract testing labsand distribution centers including review and approval of quality system records including, but not limited to batch records, deviations and qualifications.  The individual will also work cross-functionally to develop, implement, and improve processes to support the start-up and operation of internal GMP manufacturing capabilities.

Essential Functions and Duties

  • Ownership of the batch disposition process for externally manufactured products
  • Serve as primary liaison to CMOs, CTLs, and distributors
  • Oversight of quality activities associated with manufacturing and testing of clinical materials
  • Batch record review and approval
  • Tech Transfer and Validation support
  • Review and approval of QC activities including: testing, method qualification/validation, and stability protocols/reports
  • Support regulatory authority inspections and partner audits
  • QA oversight of quality system records including: Deviation, CAPA, Change Control, and Investigations
  • Support establishment and management of the quality metrics program

Skills and Experience

  • Bachelor’s degree in life sciences, engineering, or equivalent
  • Minimum 8 years of experience in the pharmaceutical or biotech industry in QA operations and direct experience working with Quality Systems, specifically batch record review and disposition
  • Ability to lead, problem solve, and work autonomously in a dynamic manufacturing environment
  • Ability to apply a phase appropriate, risk-based approach to QA operational decisions
  • Comprehensive knowledge of GMP regulations and guidelines
  • Experience with tech transfer, qualifications and validations
  • Direct experience with biologics Drug Substance and Drug Product manufacturing
  • Excellent technical, organizational, communication, and interpersonal skills are essential
  • Flexibility to accommodate to rapidly changing priorities and deadlines
  • Auditing experience a plus

 

Interested candidates should forward a cover letter and Resume / CV to careers@homologymedicines.com

 

 

Homology Medicines, Inc. (HMI) has built foundational intellectual property on gene editing and gene therapy vectors derived from naturally occurring human adeno-associated viruses (AAVs). The Company's technology is precise, on-target and highly efficient for in vivo editing of genetic mutations. This transformative platform technology, combined with an elite leadership team of biopharmaceutical industry veterans, create a significant opportunity for HMI to rapidly advance a diverse pipeline of new medicines that address and potentially cure the underlying cause of genetic diseases.

Company


Homology Medicines is based on groundbreaking science that harnesses the naturally occurring process of homologous recombination. This non-nuclease-based approach offers clear advantages in its precision, efficiency and on-target in vivo editing of genetic mutations. Homology obtained an exclusive worldwide license to this technology platform, which is based on the pioneering research of Saswati Chatterjee, Ph.D., Professor of Virology at the Beckman Research Institute at the City of Hope in California, member of the Recombinant DNA Advisory Committee (RAC) to the Office of the Director, National Institutes of Health (NIH) and former charter member of the Therapeutic Approaches to Genetic Diseases Study Section of the NIH. Dr. Chatterjee and her team led the first adeno-associated virus (AAV) vector-mediated gene transfer studies into human hematopoietic stem cells and subsequently identified and isolated a series of naturally-occurring AAVs from human CD34+ cells.

YEAR FOUNDED:

2015

LEADERSHIP:

Founder: Saswati Chatterjee

President and CEO: Arthur Tzianabos, Ph.D.

CSO: Albert Seymour, Ph.D.

Company info
Website
Phone
857-305-1825
Location
1 Patriot Place
Bedford
Massachusetts
01730
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert